InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Bishop John E, Chief Technology Officer. Insider active across 3 companies, notably Forma Therapeutics Holdings, Inc.. In total, 6 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €12k. Activity tracked since 14 June 2021. The latest transaction was disclosed on 21 May 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
2,306 shares@ US$6.26750.0009% mcap100.0% of flowCommon StockSEC:0001308911-26-000004:0
47,950 sharesCommon StockSEC:0000899243-22-033652:0
25,950 shares0Common StockSEC:0000899243-22-008643:0
22,000 shares0Common StockSEC:0000899243-21-023855
22,000 shares0Common StockSEC:0000899243-21-023855:0
17,100 sharesCommon StockSEC:0001179110-16-018966:0
6 of 6 declarations
About Bishop John E
John E. Bishop is Chief Technology Officer and Senior Vice President of Forma Therapeutics Holdings, Inc. In this role, he oversees the company's technological initiatives and innovation. John brings valuable expertise in health technology, thereby contributing to the strategic direction of Forma Therapeutics. His commitment to innovation is an asset for the company.
